The funding debate in Congress is over immigration-enforcement practices, but the Administration is still spending ...
Findings presented at the 2026 ASCO GU Symposium show that combinatorial therapies may provide new treatment options for patients with renal cell carcinoma or muscle-invasive bladder cancer.
SAN FRANCISCO -- The adjuvant combination of pembrolizumab (Keytruda) and belzutifan (Welireg) significantly improved disease ...
Plan your Fetch Charlotte schedule with these lectures to watch.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results